Sign in
4

Changes in Ownership

Arcus Biosciences, Inc. Filed Acc 0001724521-23-000011

Chief Operating Officer sold 21,369 shares at $19.99 ($427,166)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jarrett Jennifer · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-22 Sale : show line 1 in the form 10b5-1 −21,369 $19.99 $427,166 302,691 D
Open-market sales · 21,369 sh · avg $19.99 · $427,166
Loading xslF345X05/wk-form4_1695760547.xml…